Well done Italy!
#worldkidneycancerday
#WKCD25
Well done Italy!
#worldkidneycancerday
#WKCD25
⏩VEGF and its receptor (VEGFR) inhibitors- sorafenib, sunitinib, bevacizumab, pazopanib and axitinib
⏩mTORC1 inhibitors- everolimus, temsirolimus have been approved
🔗 pubmed.ncbi.nlm.nih.gov/28276433/
#WKCD25 #Medsky #Nephsky
⏩VEGF and its receptor (VEGFR) inhibitors- sorafenib, sunitinib, bevacizumab, pazopanib and axitinib
⏩mTORC1 inhibitors- everolimus, temsirolimus have been approved
🔗 pubmed.ncbi.nlm.nih.gov/28276433/
#WKCD25 #Medsky #Nephsky
✂️Localized RCC can be successfully managed with surgery, whereas metastatic RCC is refractory to conventional chemotherapy
🔗 pubmed.ncbi.nlm.nih.gov/28276433/
#WKCD25 #Medsky #Nephsky
✂️Localized RCC can be successfully managed with surgery, whereas metastatic RCC is refractory to conventional chemotherapy
🔗 pubmed.ncbi.nlm.nih.gov/28276433/
#WKCD25 #Medsky #Nephsky
🔅Staging of renal cell carcinoma (RCC) is based on size, position and lymph node involvement
🔗 pubmed.ncbi.nlm.nih.gov/25691606/
#WKCD25 #Medsky #Nephsky
🔅Staging of renal cell carcinoma (RCC) is based on size, position and lymph node involvement
🔗 pubmed.ncbi.nlm.nih.gov/25691606/
#WKCD25 #Medsky #Nephsky
🩸Clinically- flank pain, gross hematuria and a palpable abdominal mass
🔅Paraneoplastic syndromes like hypercalcemia, fever and erythrocytosis are not uncommon
🔗 pmc.ncbi.nlm.nih.gov/articles/PMC...
#WKCD25 #Medsky #Nephsky
🩸Clinically- flank pain, gross hematuria and a palpable abdominal mass
🔅Paraneoplastic syndromes like hypercalcemia, fever and erythrocytosis are not uncommon
🔗 pmc.ncbi.nlm.nih.gov/articles/PMC...
#WKCD25 #Medsky #Nephsky
✅VHL mutation and 3p loss of heterozygosity are early events evident in all ccRCC cells
🧬Common driver mutations (SETD2, MTOR and KDM5C mutations) are often present heterogeneously — suggestive of sub clonal evolution of the tumor
🔗 pubmed.ncbi.nlm.nih.gov/22397650/
#WKCD25 #Medsky #Nephsky
✅VHL mutation and 3p loss of heterozygosity are early events evident in all ccRCC cells
🧬Common driver mutations (SETD2, MTOR and KDM5C mutations) are often present heterogeneously — suggestive of sub clonal evolution of the tumor
🔗 pubmed.ncbi.nlm.nih.gov/22397650/
#WKCD25 #Medsky #Nephsky
🧬Loss of VHL is the most frequent genetic feature of ccRCC
🚨It leads to aberrant accumulation of HIF proteins, uncontrolled activation of HIF target genes that regulate angiogenesis, glycolysis and apoptosis
🔗https://pubmed.ncbi.nlm.nih.gov/24491179/
#WKCD25 #Medsky #Nephsky
🧬Mutations in at least 11 genes (BAP1, FLCN, FH, MET, PTEN, SDHB, SDHC, SDHD, TSC1, TSC2, and VHL)
🧬VHL- the mutated gene underlying von Hippel-Lindau disease, is characterized by a high risk of developing ccRCC
🔗https://pubmed.ncbi.nlm.nih.gov/18039096/
#WKCD25 #Nephsky
📍Constitutes 2% of cancer diagnosis and cancer deaths 🌏
🔅Annually,
~295,000 new kidney cancer cases are diagnosed
~134,000 deaths are recorded worldwide
🔗https://pubmed.ncbi.nlm.nih.gov/26181261/
🔗https://pubmed.ncbi.nlm.nih.gov/38341277/
#WKCD25 #Nephsky
@hswapnil.medsky.social
📍Constitutes 2% of cancer diagnosis and cancer deaths 🌏
🔅Annually,
~295,000 new kidney cancer cases are diagnosed
~134,000 deaths are recorded worldwide
🔗https://pubmed.ncbi.nlm.nih.gov/26181261/
🔗https://pubmed.ncbi.nlm.nih.gov/38341277/
#WKCD25 #Nephsky
@hswapnil.medsky.social
⁉️Do you know how many people worldwide are diagnosed with kidney cancer every year?
🚨Around 431,000!!
#WorldKidneyCancerDay
#WKCD25 #Medsky #Nephsky
@ikccorg.bsky.social @myadla.bsky.social
⁉️Do you know how many people worldwide are diagnosed with kidney cancer every year?
🚨Around 431,000!!
#WorldKidneyCancerDay
#WKCD25 #Medsky #Nephsky
@ikccorg.bsky.social @myadla.bsky.social
Visit the website for resources and more information: www.worldkidneycancerday.org #WKCD25
Visit the website for resources and more information: www.worldkidneycancerday.org #WKCD25